CTRI/2023/03/050191Not yet recruitingPhase 4
clinical study to compare the effect of bolus inj mephentermine and inj phenylephrine for management of hypotension during caesarean section performed under subarachnoid block
Dr Shambhawi Tiwari0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Full term parturient of age 20 -35 years.
- •2. American society of Anaesthesiologistsclass 1 and 2
- •3. Scheduled for caesarean section under subarachnoid block during the study period.
Exclusion Criteria
- •1. Patient refusal
- •2. Below 20 years and more than 35 years.
- •3. H/O hypertension, preeclampsia, eclampsia,hyperthyroidism, any coexisting neurological , cerebrovascular, renal , metabolic, psychiatric, occulovascular disorder.
- •4. Having known fetal abnormalities and fetal distress.
Investigators
Similar Trials
Not yet recruiting
Phase 3
A study to compare the effect of dexmedetomidine versus ketamine in fracture femur patientsCTRI/2022/05/042695izams Institute of medical sciences Hyderabad India
Not yet recruiting
Phase 2
Comparative study of use of intravenous bolus dose of mephentermine with norepinephrine in management of spinal anesthesia induced hypotension in lower segment caesarean section surgeriesCTRI/2022/08/044813Institute of Medical Sciences Banaras Hindu University
Recruiting
Not Applicable
Comparison of two methods of bowel feeding and continuous in intensive care patientsIRCT20100124003146N10Kashan University of Medical Sciences74
Not yet recruiting
Phase 4
Comparison of effects of two different methods of giving magnesium sulphate for reducing pain after uterus removal surgeryCTRI/2019/10/021615niversity College of Medical Sciences and Guru Teg Bahadur hospital
Recruiting
Not Applicable
Comparison of Bolus Versus Continuous Infusion of Terlipressin (Drug) in Liver Cirrhotic Patients (Liver Disease)CTRI/2021/04/032537Institute of Liver and Biliary Sciences
